Microbial Cell 3-Hydroxybutyrate Secretion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing 3-hydroxybutyrate rely heavily on petroleum-based resources, leading to environmental issues and inefficiencies, as they do not effectively utilize the photosynthetic potential of cyanobacteria and require energy-intensive processes for extraction.

Innovation Solution

A genetically modified microbial cell capable of converting acetoacetate to 3-hydroxybutyrate, with increased expression of specific enzymes, allowing for efficient production without the need for separation steps and utilizing carbon sources like CO2 and CO, reducing waste and fossil fuel dependency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If petroleum-based methods are used for producing 3-hydroxybutyrate, then production can be achieved through conventional chemical processes, but environmental pollution increases and renewable resource utilization is lost

Engineering Contradiction:
Improveproduction methodVSAvoidenvironmental pollution
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The patent converts waste gases (CO and CO2) that would otherwise be harmful emissions into valuable carbon sources for 3-hydroxybutyrate production. The engineered microorganism metabolizes these waste gases through the C1 pathway to produce 3-hydroxybutyrate, transforming environmental pollutants into useful bioproducts and eliminating the need for petroleum-based feedstocks

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent fundamentally changes the carbon source parameter from petroleum-based chemicals to gaseous carbon sources (CO and CO2). By engineering metabolic pathways that utilize the C1 pathway, the system accepts gaseous substrates and converts them through acetyl-CoA to 3-hydroxybutyrate, representing a paradigm shift from liquid chemical feedstocks to gas-phase carbon sources

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If cyanobacteria photosynthetic potential is not utilized, then genetic engineering strategies can be applied, but the photosynthetic capability remains underused and process complexity increases

Engineering Contradiction:
Improvegenetic engineering strategyVSAvoidphotosynthetic potential utilization
Core Design Contradiction:
Ease of manufactureVSUse of energy by moving object

Solution Approach 1:

The patent creates a microorganism system that performs multiple functions: it maintains photosynthetic capability while simultaneously metabolizing gaseous carbon sources through the C1 pathway. The engineered organism can utilize both photosynthesis and waste gas metabolism to produce 3-hydroxybutyrate, making the system versatile and eliminating the need for separate nitrogen starvation and substrate supplementation stages

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If energy-intensive extraction processes are used for PHB, then product recovery can be achieved, but energy consumption increases and production efficiency decreases

Engineering Contradiction:
Improveproduct recoveryVSAvoidextraction energy
Core Design Contradiction:
ProductivityVSUse of energy by moving object

Solution Approach 1:

The patent replaces the mechanical/chemical extraction process with a metabolic secretion process. Instead of producing PHB that requires energy-intensive extraction, the engineered microorganism directly secretes 3-hydroxybutyrate into the culture medium through modified metabolic pathways, eliminating the need for cell disruption and extraction equipment while significantly reducing energy consumption

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Productivity

If multi-stage cultivation process is used for PHB biosynthesis, then PHB production can be achieved, but process complexity increases and production time extends

Engineering Contradiction:
ImprovePHB biosynthesisVSAvoidcultivation process
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent implements a continuous single-stage cultivation process where the engineered microorganism continuously produces and secretes 3-hydroxybutyrate throughout the growth phase. By eliminating the nitrogen starvation transition and continuous substrate supplementation required for PHB production, the system maintains continuous productive action without process interruptions or stage transitions

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enhances production efficiency, simplifies the process, and reduces waste by enabling the microbial cell to produce 3-hydroxybutyrate directly from waste gases, leveraging renewable resources and the photosynthetic capabilities of cyanobacteria.

Implementation Method 1

an enzyme E1 capable of catalysing the conversion of acetyl-CoA to acetoacetyl-CoA

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

an enzyme E2 capable of catalysing the conversion of acetoacetyl-CoA to acetoacetate

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 3

an enzyme E3 capable of catalysing the conversion of acetoacetate to 3-hydroxybutyrate

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 4

Photosynthetic cyanobacteria have attracted significant attention in recent years as a 'microbial factory' to produce biofuels and chemicals due to their capability to utilize solar energy and CO2 as the sole energy and carbon sources

Methodology Applied
Scientific EffectPhotosynthesis: Photosynthesis

Data Source

PatentEP3298154B1Production of 3-hydroxybutyrate
Publication Date: 2019.09.11 EVONIK OPERATIONS GMBH
  • EP3298154B1 patent drawingFigure 1
  • EP3298154B1 patent drawing
  • EP3298154B1 patent drawing

AI summary

There is provided amicrobial cell which is capable of producing acetoacetate, 3-hydroxybutyrate and/or 3-hydroxybutyrate variants, wherein the cell is genetically modified to comprise an increased expression relative to its wild type cell of: - an enzyme E1 capable of catalysing the conversion of acetyl-CoA to acetoacetyl-CoA; - an enzyme E2 capable of catalysing the conversion of acetoacetyl-CoA to acetoacetate; and -an enzyme E3 capable of catalysing the conversion of acetoacetate to 3-hydroxybutyrate and/or variants thereof.